Crestwell Healthcare Income Statement

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	-	6.15	17.3	3.35	8.32
Revenue Growth	-	-64.48%	416.76%	-59.75%	-7.77%
Fuel & Purchased Power	-	-	-	-	0.7
Operations & Maintenance	-	2.43	-	-	0.28
Selling, General & Admin	5.33	1.67	0.54	0.18	0.29
Depreciation & Amortization	-	0	0	0	0
Other Operating Expenses	2.88	10.44	15.1	6.07	7.69
Total Operating Expenses	8.21	14.55	15.63	6.25	8.96
Operating Income	-8.21	-8.4	1.67	-2.9	-0.64
Other Non-Operating Income (Expenses)	-0	-0	-0	-0	-0
EBT Excluding Unusual Items	-8.21	-8.4	1.67	-2.9	-0.65
Pretax Income	-8.21	-8.4	1.67	-2.9	-0.65
Net Income	-8.21	-8.4	1.67	-2.9	-0.65
Net Income to Common	-8.21	-8.4	1.67	-2.9	-0.65
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18
Shares Change	-	-	-	-	-
EPS (Basic)	-0.46	-0.47	0.09	-0.16	-0.04
EPS (Diluted)	-0.46	-0.47	0.09	-0.16	-0.04
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Free Cash Flow	-0.15	-1.32	-0.56	-0.01	-1.28
Free Cash Flow Per Share	-0.01	-0.07	-0.03	-0.00	-0.07
Profit Margin	-	-136.75%	9.64%	-86.75%	-7.76%
Free Cash Flow Margin	-	-21.47%	-3.22%	-0.28%	-15.44%
EBITDA	-7.61	-7.74	2.4	-2.09	-0.19
EBITDA Margin	-	-125.98%	13.88%	-62.42%	-2.28%
D&A For EBITDA	0.6	0.66	0.73	0.81	0.45
EBIT	-8.21	-8.4	1.67	-2.9	-0.64
EBIT Margin	-	-136.70%	9.65%	-86.71%	-7.75%